05/14/2025 10:59 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
05/14/2025 9:47 AM | Ascendis Pharma A/S (Subject) T. Rowe Price Investment Management, Inc. (Filed by)
| Form SCHEDULE 13G | |
05/12/2025 11:13 AM | Ascendis Pharma A/S (Subject) Shu Aimee (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2025 6:18 AM | Ascendis Pharma A/S (Subject) Shu Aimee (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/05/2025 3:14 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/01/2025 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2025 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/31/2025 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/20/2025 3:17 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2025 3:48 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/07/2025 4:03 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Get the Latest News and Ratings for ASND and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ascendis Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.
|
03/05/2025 3:51 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/05/2025 1:31 PM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:38 PM | Ascendis Pharma A/S (Subject) Hartvig Camilla Harder (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:27 PM | Ascendis Pharma A/S (Subject) Fairey William (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:32 PM | Ascendis Pharma A/S (Subject) Bodenhoff Mads (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:15 PM | Ascendis Pharma A/S (Subject) Morrison Lisa (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:22 PM | Ascendis Pharma A/S (Subject) IMANI SIHAM (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:50 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:55 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:00 PM | Ascendis Pharma A/S (Subject) SMITH SCOTT THOMAS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:04 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:09 PM | Ascendis Pharma A/S (Subject) Cha Albert (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 7:12 PM | Ascendis Pharma A/S (Subject) HOLTUG LARS (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:40 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2025 6:45 PM | Ascendis Pharma A/S (Subject) SPROGOE KENNETT (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 3:02 PM | Ascendis Pharma A/S (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/21/2025 5:11 AM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 4:06 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/19/2025 3:56 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2025 10:54 AM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
02/12/2025 3:15 PM | Ascendis Pharma A/S (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
02/12/2025 2:24 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/11/2025 8:15 AM | Ascendis Pharma A/S (Subject) WESTFIELD CAPITAL MANAGEMENT CO LP (Filed by)
| Form SCHEDULE 13G/A | |
01/15/2025 3:39 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:03 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/13/2025 5:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/30/2024 3:04 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/17/2024 5:04 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/10/2024 4:02 PM | Ascendis Pharma A/S (Subject) PEDERSEN ANNI LOTTE KIRSTINE SONDERBJERG (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 4:07 PM | Ascendis Pharma A/S (Subject) JENSEN MICHAEL WOLFF (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
Trump wipes out trillions overnight… (Ad) Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move. Whether you take some of that wealth for yourself depends on if you watch this controversial exposé |
12/10/2024 4:16 PM | Ascendis Pharma A/S (Subject) SINGEL STINA (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/10/2024 3:44 PM | Ascendis Pharma A/S (Subject) MIKKELSEN JAN MOLLER (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/03/2024 3:35 PM | Ascendis Pharma A/S (Subject) JENSEN FLEMMING STEEN (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024 4:46 PM | Ascendis Pharma A/S (Subject) RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SC 13G/A | |
11/14/2024 1:57 PM | Ascendis Pharma A/S (Subject) JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024 8:31 AM | Ascendis Pharma A/S (Subject) Avoro Capital Advisors LLC (Filed by)
| Form SC 13G/A | |
11/13/2024 3:02 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/12/2024 8:51 AM | Artisan Partners Limited Partnership (Filed by) Ascendis Pharma A/S (Subject)
| Form SC 13G/A | |
11/08/2024 9:34 AM | Ascendis Pharma A/S (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
11/04/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/30/2024 7:35 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/27/2024 3:59 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/18/2024 4:20 PM | Ascendis Pharma A/S (Filer)
| Form 424B5 | |
09/18/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form F-3ASR | |
09/16/2024 6:28 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 6:32 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/11/2024 3:01 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:10 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:11 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/03/2024 4:14 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/12/2024 6:05 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/28/2024 5:07 AM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/31/2024 3:26 PM | Ascendis Pharma A/S (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/29/2024 3:08 PM | Ascendis Pharma A/S (Filer)
| Form SD Specialized Disclosure Report | |